Live Update 
From the Liveblog of
Thursday, March 4, 2021
From the Liveblog of
Thursday, March 4, 2021
EU antitrust authorities launch official probe of Teva over Copaxone drug
Add ToI as a Preferred Source on GoogleEuropean Union antitrust authorities will formally probe Israeli drugmaker Teva, Reuters reports, over suspicions it took illegal steps to thwart rivals on its Copaxone drug, used to treat multiple sclerosis.
A preliminary probe was opened late last year, leading to the latest decision.
If you’d like to comment, join
The Times of Israel Community.
The Times of Israel Community.
JOIN THE TOI COMMUNITY
Already a member? Log in here